New Nanoparticles for Tamoxifen Delivery
Author Information
Author(s): Cavalli R., Bisazza A., Bussano R., Trotta M., Civra A., Lembo D., Ranucci E., Ferruti P.
Primary Institution: Università di Torino
Hypothesis
Can poly(amidoamine)-cholesterol conjugate nanoparticles be effectively used for tamoxifen delivery?
Conclusion
The study found that tamoxifen-loaded nanoparticles showed enhanced cytotoxicity compared to free tamoxifen and did not exhibit any toxic effects themselves.
Supporting Evidence
- The nanoparticles showed sizes lower than 500 nm and a spherical shape.
- Tamoxifen-loaded nanoparticles exhibited a higher dose-dependent cytotoxicity than free tamoxifen.
- The drug loading capacity of the nanoparticles was about 40%.
Takeaway
Scientists created tiny balls called nanoparticles to deliver a cancer drug called tamoxifen better, making it work more effectively without harming healthy cells.
Methodology
The nanoparticles were created using an electrospraying technique, which involves dispersing a polymer solution into small charged droplets using an electric field.
Limitations
The study did not specify the long-term effects of the nanoparticles or their behavior in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website